Leuprolide Acetate Kit
Product Images NDC 72603-344

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Leuprolide Acetate (NDC 72603-344). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Leuprolide-outercarton (Leuprolide Outer Carton)

Leuprolide Acetate Injection 14 mg/2.8 mL kit packaging label from NorthStar RxLLC. The label states the product is sterile and for subcutaneous injection, with a concentration of 1 mg per 0.2 mL. The kit includes one 2.8 mL vial of Leuprolide Acetate, 14 disposable syringes, 28 alcohol swabs, and prescribing and administration information. The label also includes storage instructions to keep below 77°F and protect from light. Manufactured by Northstar Rx LLC and Pharmaceuticals International Inc.*

FDA Label Image

Leuprolide-innercarton (Vial Carton)

Leuprolide Acetate Injection 14 mg/2.8 mL (1 mg/0.2 mL) multi-dose vial label for subcutaneous injection. The label displays active ingredient information, storage instructions, usual dosage, and manufacturer details. It includes the NDC 72603-201-01 and emphasizes that the product is sterile and Rx only. Manufactured by Northstar Rx LLC, Memphis, TN.*

FDA Label Image

Chemicalstructure (Chemicalstructure)

Chemical structure of Leuprolide Acetate, showing its detailed molecular composition including peptide bonds and side chains characteristic of this synthetic nonapeptide.*

FDA Label Image

Figurea (Figa)

An instructional black-and-white line drawing labeled Figure A, showing a hand holding a syringe. The illustration focuses on the syringe's barrel and plunger, depicting the process of preparing an injection, likely demonstrating how to manipulate the syringe.*

FDA Label Image

Figureb (Figb)

An instructional black-and-white illustration showing a person washing hands under a running faucet, demonstrating hand hygiene technique.*

FDA Label Image

Figurec (Figc)

An instructional illustration labeled 'Figure C' showing a person using a finger and thumb to twist off or remove a flip-top cap from a vial or bottle. The image focuses on the action of opening the container, likely related to medication preparation or administration.*

FDA Label Image

Figured (Figd)

An instructional illustration showing a close-up of two fingers holding a small vial or container, likely demonstrating a step in the preparation or administration process related to the Leuprolide Acetate subcutaneous kit.*

FDA Label Image

Figuref (Figf)

An instructional illustration showing how to attach a needle to a syringe. The image depicts two hands, one holding the needle and the other holding the syringe, with the needle about to be connected to the syringe tip. Labeled as Figure F.*

FDA Label Image

Figureg (Figg)

An instructional black-and-white illustration showing two hands preparing a syringe by drawing liquid from a small vial. The image is labeled as Figure G and depicts a step in medication preparation, relevant to the Leuprolide Acetate subcutaneous injection kit.*

FDA Label Image

Figureh (Figh)

An instructional illustration depicting a hand holding a vial upside down with a syringe needle inserted into the vial's rubber stopper, demonstrating the technique of drawing liquid from a vial.*

FDA Label Image

Figurei (Figi)

An instructional illustration showing two hands preparing a syringe by drawing medication from a vial. One hand holds the vial upside down, and the other hand pulls back the syringe plunger to fill it. The image highlights the proper method for withdrawing the medication.*

FDA Label Image

Figurej (Figj)

An instructional illustration showing a hand holding a syringe injecting the substance subcutaneously into the skin of another hand. The image depicts the technique of subcutaneous injection, with one hand stabilizing the skin and the other administering the injection.*

FDA Label Image

Figurek (Figk)

An instructional black-and-white line drawing showing two hands performing a subcutaneous injection. One hand holds a syringe vertically above the skin, with an arrow indicating upward motion. The other hand presses a pad against the injection site on the skin. The figure is labeled 'Figure K.'*

FDA Label Image

Figurel (Figl)

An instructional illustration showing a hand disposing of a syringe into a sharps disposal container. The image emphasizes safe disposal practices for used needles, relevant for subcutaneous administration kits like the Leuprolide Acetate kit.*

FDA Label Image

Figurem (Figm)

An instructional black-and-white illustration labeled 'Figure L' shows a hand holding a syringe above an open sharps disposal container. The image demonstrates safe disposal of the syringe into the container.*

FDA Label Image

Leuprolide-label (Vial Label)

Leuprolide Acetate Injection 14 mg/2.8 mL (1 mg/0.2 mL) sterile multi-dose vial label for subcutaneous injection. The label indicates the active ingredient strength, dosage form, storage instructions, manufacturer Northstar RX LLC, and includes barcode and lot/expiration fields.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.